The U.S. Food & Drug Administration's good manufacturing practice (GMP) inspections of dietary supplement facilities is back up to 500 per year, a return to pre-COVID levels, but those levels are still inadequate, says Dr. Cara Welch, FDA’s director of the Office of Dietary Supplement Programs (ODSP).
In his quarterly FDA warning letter roundup, dietary supplement consultant Asa Waldstein reviews trends over the last quarter and year, and he makes 2024 predictions.